362 related articles for article (PubMed ID: 20873244)
1. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
[TBL] [Abstract][Full Text] [Related]
2. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
3. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
4. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
5. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.
Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T
Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837
[TBL] [Abstract][Full Text] [Related]
7. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
[TBL] [Abstract][Full Text] [Related]
8. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.
Stephens JW; Bodvarsdottir TB; Wareham K; Prior SL; Bracken RM; Lowe GD; Rumley A; Dunseath G; Luzio S; Deacon CF; Holst JJ; Bain SC
Diabetes Res Clin Pract; 2011 Nov; 94(2):199-206. PubMed ID: 21835486
[TBL] [Abstract][Full Text] [Related]
10. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.
Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C
Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608
[TBL] [Abstract][Full Text] [Related]
11. High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA
Jakubowicz D; Wainstein J; Landau Z; Ahren B; Barnea M; Bar-Dayan Y; Froy O
J Nutr Biochem; 2017 Nov; 49():1-7. PubMed ID: 28863364
[TBL] [Abstract][Full Text] [Related]
12. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Esposito K; Giugliano D; Nappo F; Marfella R;
Circulation; 2004 Jul; 110(2):214-9. PubMed ID: 15197140
[TBL] [Abstract][Full Text] [Related]
13. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.
Bellomo Damato A; Stefanelli G; Laviola L; Giorgino R; Giorgino F
Diabet Med; 2011 May; 28(5):560-6. PubMed ID: 21204958
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.
Raz I; Stranks S; Filipczak R; Joshi P; Lertoft B; Rastam J; Chow CC; Shaban J
Clin Ther; 2005 Sep; 27(9):1432-43. PubMed ID: 16291416
[TBL] [Abstract][Full Text] [Related]
15. Restricting carbohydrates at breakfast is sufficient to reduce 24-hour exposure to postprandial hyperglycemia and improve glycemic variability.
Chang CR; Francois ME; Little JP
Am J Clin Nutr; 2019 May; 109(5):1302-1309. PubMed ID: 30968140
[TBL] [Abstract][Full Text] [Related]
16. Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes.
Hussain SA
J Med Food; 2007 Sep; 10(3):543-7. PubMed ID: 17887949
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.
Hoffmann J; Spengler M
Diabetes Care; 1994 Jun; 17(6):561-6. PubMed ID: 8082525
[TBL] [Abstract][Full Text] [Related]
18. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
19. A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1
Ma J; He H; Yang X; Chen D; Tan C; Zhong L; Du Q; Wu X; Gao Y; Liu G; Wang C; Ran X
Nutr Diabetes; 2021 Jun; 11(1):14. PubMed ID: 34088897
[TBL] [Abstract][Full Text] [Related]
20. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
Galic E; Vrtovec M; Bozikov V; Schwarzenhofer M; Milicevic Z
Med Sci Monit; 2005 Dec; 11(12):PI87-92. PubMed ID: 16319804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
